PAUL HARTMANN AG (PHH2) AI Stock Analysis

1 Followers

PAUL HARTMANN AG

(Frankfurt:PHH2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

PAUL HARTMANN AG (PHH2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 673.06M
Dividend Yield: 4.22%
Average Volume (3M): 72
Price to Earnings (P/E): 6.7
Beta (1Y): 0.21
Revenue Growth: 2.52%
EPS Growth: 22.56%
Country: Germany
Employees: 10,479
Sector: General
Sector Strength: 55
Industry: Medical Equipment & Supplies

PAUL HARTMANN AG Business Overview & Revenue Model

Company Description

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compressi...

PAUL HARTMANN AG Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

DE:PHH2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:SHL	77Outperform	EUR 47.91B	21.98	11.72%	2.30%	1.09%	3.52%
DE:DMP	65Neutral	EUR 1.91B	13.94	22.38%	2.28%	0.39%	38.58%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
DE:FYB	45Neutral	EUR 261.91M	-10.54	-6.41%	―	18.28%	85.20%

* General Sector Average

Performance Comparison

DE:PHH2 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:PHH2	PAUL HARTMANN AG	189.50	-25.80	-11.98%
DE:DMP	Dermapharm Holding	38.60	5.57	16.87%
DE:SHL	Siemens Healthineers	43.52	1.22	2.88%
DE:BMP	B.M.P. Pharma Trading AG	6.40	1.53	31.36%
DE:HAEK	HAEMATO AG	13.00	3.68	39.47%
DE:FYB	Formycon AG	14.96	-6.04	-28.76%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

PAUL HARTMANN AG AI Stock Analysis